To assess the impact of FADS1 on tumor development in vivo, we injected wild-type (WT) and FADS1-KD 786-o cells (Supplementary Fig. S6A) into the flank of male and female severe combined immunodeficient (SCID) mice to generate tumors (Fig. 7A). This evidence concerns the gene FADS1 and neoplasm.